We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.9B
AUM Growth
+$620M
Cap. Flow
-$8.35M
Cap. Flow %
-0.14%
Top 10 Hldgs %
23.55%
Holding
3,465
New
250
Increased
687
Reduced
2,249
Closed
176

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$47.2M
2
MSFT icon
Microsoft
MSFT
+$38.2M
3
AAPL icon
Apple
AAPL
+$37M
4
AMZN icon
Amazon
AMZN
+$35.5M
5
CTRA
Coterra Energy
CTRA
+$34.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.44%
2 Technology 20.51%
3 Financials 13.46%
4 Industrials 10.73%
5 Healthcare 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRAM icon
2951
Everspin Technologies
MRAM
$405M
$1.64K ﹤0.01%
+68
New +$1.52K
NERV icon
2952
Minerva Neurosciences
NERV
$209M
$1.64K ﹤0.01%
+296
New +$1.6K
MNTK icon
2953
Montauk Renewables
MNTK
$356M
$1.63K ﹤0.01%
1,045
-801
-43% -$1.19K
ZSQR
2954
Z Squared Inc
ZSQR
$164M
$1.63K ﹤0.01%
+154
New +$1.89K
BVS icon
2955
Bioventus
BVS
$945M
$1.59K ﹤0.01%
169
-131
-44% -$1.25K
FEIM icon
2956
Frequency Electronics
FEIM
$730M
$1.59K ﹤0.01%
24
-19
-44% -$1.17K
DSGN icon
2957
Design Therapeutics
DSGN
$953M
$1.56K ﹤0.01%
108
-683
-86% -$8.52K
BRCC icon
2958
BRC Inc
BRCC
$127M
$1.55K ﹤0.01%
140
+77
+122% +$953
AKBA icon
2959
Akebia Therapeutics
AKBA
$285M
$1.55K ﹤0.01%
1,362
-6,270
-82% -$7.46K
FTK icon
2960
Flotek Industries
FTK
$883M
$1.55K ﹤0.01%
66
-302
-82% -$5.84K
FLWS icon
2961
1-800-Flowers.com
FLWS
$234M
$1.53K ﹤0.01%
441
-329
-43% -$1.3K
DOMO icon
2962
Domo
DOMO
$180M
$1.52K ﹤0.01%
485
+153
+46% +$512
MNTN
2963
MNTN Inc
MNTN
$958M
$1.52K ﹤0.01%
+165
New +$1.5K
TCX icon
2964
Tucows
TCX
$120M
$1.5K ﹤0.01%
111
-85
-43% -$1.29K
BWMN icon
2965
Bowman Consulting
BWMN
$738M
$1.49K ﹤0.01%
51
-60
-54% -$1.89K
GLIBA
2966
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.05B
$1.49K ﹤0.01%
68
-26
-28% -$735
MPTI icon
2967
M-tron Industries
MPTI
$331M
$1.49K ﹤0.01%
15
-1
-6% -$80
IMMX icon
2968
Immix Biopharma
IMMX
$943M
$1.49K ﹤0.01%
+144
New +$1.34K
NPCE icon
2969
Neuropace
NPCE
$507M
$1.48K ﹤0.01%
93
-63
-40% -$1.01K
AURA icon
2970
Aura Biosciences
AURA
$763M
$1.46K ﹤0.01%
205
-916
-82% -$6.55K
HCKT icon
2971
Hackett Group
HCKT
$281M
$1.45K ﹤0.01%
135
-77
-36% -$900
RBKB icon
2972
Rhinebeck Bancorp
RBKB
$204M
$1.45K ﹤0.01%
84
-65
-44% -$1.05K
CTGO icon
2973
Contango Silver & Gold Inc
CTGO
$669M
$1.45K ﹤0.01%
92
-43
-32% -$886
EOLS icon
2974
Evolus
EOLS
$587M
$1.45K ﹤0.01%
209
-154
-42% -$909
SOC icon
2975
Sable Offshore Corp
SOC
$931M
$1.45K ﹤0.01%
470
-338
-42% -$4.3K

Similar funds

Sterling Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Sterling Capital Management held 3,465 positions worth $5.9B, up 12% from $5.28B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management's Q2 2026 filing shows 250 new, 687 increased, 2,249 reduced and 176 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M. The largest sale was Marvell Technology, an estimated $47.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Sterling Capital Management's largest Q2 2026 buy was Coca-Cola Europacific Partners: 217,119 shares worth $21.7M.
  • Sterling Capital Management added most to Philip Morris in Q2 2026, an estimated $43.1M increase.
  • Sterling Capital Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $47.2M.
  • Sterling Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $34.4M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $5.9B portfolio in Q2 2026.
  • Sterling Capital Management opened 250 new positions and closed 176 in Q2 2026.
  • Sterling Capital Management's portfolio value rose 12% quarter-over-quarter to $5.9B.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.